Join
Live feed
·
INSIDERFilingvia Quantisnow
Alto Neuroscience Inc. logo

Apeiron Investment Group Ltd. converted options into 926,539 shares (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
ANRO· Alto Neuroscience Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ANRO (Alto Neuroscience Inc.) and more on Quantisnow.